Sticky US inflation at 3.7% and a jump in Treasury yields above 5.32% on the 10-year have reminded investors that higher rates can punish stretched valuations quickly. That kind of shock often pushes attention back to dividend value stocks with solid balance sheets and cash flows. This article walks through three high-quality dividend payers from our screener that appear relatively well set up, or at least less exposed to the current rate reset.
The three stocks highlighted below are just a sample from this dividend value idea, and the full screen surfaced 8 more large cap U.S. companies with similarly grounded income stories that are not covered here. To size up the wider universe quickly, head straight to the High-Quality Dividend Value Stocks screener to identify, filter, and analyze the highest conviction dividend value candidates.
Overview: Elevance Health is a large U.S. health benefits group that sells medical insurance, pharmacy services, and care management solutions to individuals, employers, and government programs, aligning closely with a dividend-focused, cash-generative profile.
Operations: Elevance Health generates about US$169.3b from Health Benefits and US$74.2b from Carelon Rx and Services, with essentially all revenue coming from the United States.
Market Cap: US$92.2b
Elevance Health fits this dividend value screen because recurring premiums, fee-based services, and a disciplined balance sheet can translate into relatively predictable cash flows and support for a steady payout, even as higher rates pressure more growth-dependent sectors.
"Ongoing deployment of Elevance Health’s AI, analytics and digital platforms such as HealthOS and Sydney Health, including automated prior authorization and earlier visibility into medical cost trends, is expected to tighten medical cost management and support more stable net margins and earnings over time."
What happens to Elevance Health’s appeal as a defensive income stock will depend on how one unseen pressure ultimately shapes its future margin mix.
To see how that margin pressure could either stall or accelerate Elevance Health’s cash engine, read the full narrative for Elevance Health for the full risk and runway picture.
Overview: Omega Healthcare Investors owns and rents out skilled nursing and assisted living facilities, offering income-focused investors long-term triple-net healthcare real estate exposure.
Operations: Omega Healthcare Investors generates about US$1.3b of revenue from investments in healthcare-related real estate properties, primarily through long-term rental arrangements.
Market Cap: US$14.3b
In a market where higher rates are pressuring richly valued growth stories, Omega Healthcare Investors leans into the screener’s income brief with rent-backed cash flows, long leases, and a healthcare focus that many investors treat as a ballast when inflation runs hot.
"Ongoing aging of the baby boomer population, together with limited new skilled nursing facility construction in many states, is expected to keep demand firm for Omega Healthcare Investors’ properties and support occupancy and rent coverage, which can feed through to revenue and earnings over time."
What happens if one quiet pressure on operator finances shifts, for better or worse, could define how durable that income story really is.
If that pressure point matters to your income plan, read the full narrative for Omega Healthcare Investors to see how Omega Healthcare Investors’ rent coverage and balance sheet risks could be decoupling.
Overview: NewLake Capital Partners is a cannabis focused REIT that owns cultivation and dispensary properties, collecting long term rent from licensed operators.
Operations: NewLake Capital Partners generated about US$49 million from partnership status real estate in the United States, reflecting fully domestic rental income.
Market Cap: US$290 million
NewLake Capital Partners fits this dividend value screen through contracted triple net leases, high margin rental income, and an internally managed structure that supports a regular payout. However, cannabis real estate carries more regulatory and tenant risk than mainstream REITs and remains sensitive to what happens if a single key funding channel tightens.
If that funding risk is on your radar, scan the analysis report for NewLake Capital Partners and see where NewLake Capital Partners’ income profile could quietly re rate next.
Markets move fast and the strongest ideas rarely stay under the radar for long. Scan these fresh stock lists before momentum is fully caught and entries start dropping.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com